Cargando…
T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
Neuropathic pain can appear as a direct or indirect nerve damage lesion or disease that affects the somatosensory nervous system. If the neurons are damaged or indirectly stimulated, immune cells contribute significantly to inflammatory and neuropathic pain. After nerve injury, peripheral macrophage...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387653/ https://www.ncbi.nlm.nih.gov/pubmed/37529702 http://dx.doi.org/10.3389/fphar.2023.1212800 |
_version_ | 1785081931182899200 |
---|---|
author | Rangel-Galván, Maricruz Rangel-Galván, Violeta Rangel-Huerta, Alejandro |
author_facet | Rangel-Galván, Maricruz Rangel-Galván, Violeta Rangel-Huerta, Alejandro |
author_sort | Rangel-Galván, Maricruz |
collection | PubMed |
description | Neuropathic pain can appear as a direct or indirect nerve damage lesion or disease that affects the somatosensory nervous system. If the neurons are damaged or indirectly stimulated, immune cells contribute significantly to inflammatory and neuropathic pain. After nerve injury, peripheral macrophages/spinal microglia accumulate around damaged neurons, producing endogenous hydrogen sulfide (H(2)S) through the cystathionine-γ-lyase (CSE) enzyme. H(2)S has a pronociceptive modulation on the Ca(v)3.2 subtype, the predominant Ca(v)3 isoform involved in pain processes. The present review provides relevant information about H(2)S modulation on the Ca(v)3.2 T-type channels in neuropathic pain conditions. We have discussed that the dual effect of H(2)S on T-type channels is concentration-dependent, that is, an inhibitory effect is seen at low concentrations of 10 µM and an augmentation effect on T-current at 100 µM. The modulation mechanism of the Ca(v)3.2 channel by H(2)S involves the direct participation of the redox/Zn(2+) affinity site located in the His191 in the extracellular loop of domain I of the channel, involving a group of extracellular cysteines, comprising C114, C123, C128, and C1333, that can modify the local redox environment. The indirect interaction pathways involve the regulation of the Ca(v)3.2 channel through cytokines, kinases, and post-translational regulators of channel expression. The findings conclude that the CSE/H(2)S/Ca(v)3.2 pathway could be a promising therapeutic target for neuropathic pain disorders. |
format | Online Article Text |
id | pubmed-10387653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103876532023-08-01 T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions Rangel-Galván, Maricruz Rangel-Galván, Violeta Rangel-Huerta, Alejandro Front Pharmacol Pharmacology Neuropathic pain can appear as a direct or indirect nerve damage lesion or disease that affects the somatosensory nervous system. If the neurons are damaged or indirectly stimulated, immune cells contribute significantly to inflammatory and neuropathic pain. After nerve injury, peripheral macrophages/spinal microglia accumulate around damaged neurons, producing endogenous hydrogen sulfide (H(2)S) through the cystathionine-γ-lyase (CSE) enzyme. H(2)S has a pronociceptive modulation on the Ca(v)3.2 subtype, the predominant Ca(v)3 isoform involved in pain processes. The present review provides relevant information about H(2)S modulation on the Ca(v)3.2 T-type channels in neuropathic pain conditions. We have discussed that the dual effect of H(2)S on T-type channels is concentration-dependent, that is, an inhibitory effect is seen at low concentrations of 10 µM and an augmentation effect on T-current at 100 µM. The modulation mechanism of the Ca(v)3.2 channel by H(2)S involves the direct participation of the redox/Zn(2+) affinity site located in the His191 in the extracellular loop of domain I of the channel, involving a group of extracellular cysteines, comprising C114, C123, C128, and C1333, that can modify the local redox environment. The indirect interaction pathways involve the regulation of the Ca(v)3.2 channel through cytokines, kinases, and post-translational regulators of channel expression. The findings conclude that the CSE/H(2)S/Ca(v)3.2 pathway could be a promising therapeutic target for neuropathic pain disorders. Frontiers Media S.A. 2023-07-17 /pmc/articles/PMC10387653/ /pubmed/37529702 http://dx.doi.org/10.3389/fphar.2023.1212800 Text en Copyright © 2023 Rangel-Galván, Rangel-Galván and Rangel-Huerta. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Rangel-Galván, Maricruz Rangel-Galván, Violeta Rangel-Huerta, Alejandro T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions |
title | T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions |
title_full | T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions |
title_fullStr | T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions |
title_full_unstemmed | T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions |
title_short | T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions |
title_sort | t-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387653/ https://www.ncbi.nlm.nih.gov/pubmed/37529702 http://dx.doi.org/10.3389/fphar.2023.1212800 |
work_keys_str_mv | AT rangelgalvanmaricruz ttypecalciumchannelmodulationbyhydrogensulfideinneuropathicpainconditions AT rangelgalvanvioleta ttypecalciumchannelmodulationbyhydrogensulfideinneuropathicpainconditions AT rangelhuertaalejandro ttypecalciumchannelmodulationbyhydrogensulfideinneuropathicpainconditions |